Neurodermatitis
RecruitingICP-332 for Adults with Prurigo Nodularis
ICP-332 for Adults with Prurigo Nodularis
- Disease:Neurodermatitis
- Substances:–
Poland- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Back to Poland1 824 clinical trials in Warsaw, Poland across 33 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)ICP-332 for Adults with Prurigo Nodularis
PolandRO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes
PolandComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
PolandRO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
PolandLong-Term Study of Imeroprubart in Adults With Graves' Disease
PolandCenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect
PolandBelzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy
PolandAZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
PolandTulisokibart for Psoriatic Arthritis in Adults
PolandA study to evaluate the safety and effectiveness of MB-001 in adults with moderate to severe ulcerative colitis
PolandA study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.
PolandA study to evaluate the effectiveness and safety of clemizole hydrochloride as an additional treatment for patients with Lennox-Gastaut syndrome
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) prevention in older adults. Studies include evaluation of novel vaccine formulations and immune responses in various age groups.
Particular emphasis on vaccine development for adults aged 60 and older.
Comprehensive research on meningococcal vaccines across different age groups, from infants to toddlers. Studies evaluate safety profiles and immune responses to various vaccine formulations.
Focus on preventive healthcare through advanced vaccination strategies.
Studies investigating treatments for psoriasis and psoriatic arthritis, including novel biological therapies and their mechanisms of action.
Emphasis on moderate to severe cases requiring advanced therapeutic interventions.
Clinical research focusing on bladder cancer and innovative combination therapies. Studies evaluate treatment efficacy in early-stage non-muscle invasive cases.
Integration of targeted therapies with standard treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.